CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,179,608 | +156.0% | 624,259 | +215.7% | 1.08% | +146.9% |
| Q2 2023 | $6,709,929 | -55.5% | 197,758 | -52.8% | 0.44% | -54.5% |
| Q1 2023 | $15,089,904 | +1059.0% | 419,397 | +768.2% | 0.96% | +793.5% |
| Q2 2022 | $1,302,000 | -87.6% | 48,304 | -82.2% | 0.11% | -82.4% |
| Q4 2021 | $10,492,000 | +41.8% | 271,533 | +98.2% | 0.61% | +40.0% |
| Q3 2021 | $7,398,000 | +64.2% | 137,032 | +1.7% | 0.44% | +68.5% |
| Q2 2021 | $4,505,000 | – | 134,724 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |